A Therapeutic Update on Emerging Combination Regimens to Improve Outcomes for Patients with Advanced Renal Cell Carcinoma

A Therapeutic Update on Emerging Combination Regimens to Improve Outcomes for Patients with Advanced Renal Cell Carcinoma is organized by Academic CME and will be held during May 24, 2017 - May 23, 2018.

The target audience for this medical event is Oncologists, primary care physicians, and other healthcare clinicians responsible for the care of patients with renal cell carcinoma. This CME Conference has been approved for a maximum of 1.00 AMA PRA Category 1 Credits.

Conference Objectives are :
• Review pathogenesis and the role of multi-targeted kinase inhibitors for the treatment of advanced renal cell carcinoma.
• Analyze clinical trial data of emerging combination therapy options for the treatment of advanced renal cell carcinoma presented at ASCO GU 2017.

Additional details will be posted as soon as they are available.